Scandinavian Journal of Rheumatology logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 35, Number 3, May 2006

< previous issue | all issues | next issue >

Articles

Risk factors for the development of rheumatoid arthritis
pp. 169-174(6)
Authors: Oliver, J. E.; Silman, A. J.

Interleukin‐1β influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis
pp. 182-188(7)
Authors: Kopp, S.; Alstergren, P.; Ernestam, S.; Nordahl, S.; Bratt, J.

The activity of exoglycosidases in the synovial membrane and knee fluid of patients with rheumatoid arthritis and juvenile idiopathic arthritis
pp. 189-192(4)
Authors: Popko, J.; Marciniak, J.; Zalewska, A.; Małdyk, P.; Rogalski, M.; Zwierz, K.

Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis
pp. 193-200(8)
Authors: Zurawa‐Janicka, D.; Renke, J.; Popadiuk, S.; Skorko‐Glonek, J.; Szumera, M.; Plata‐Nazar, K.; Ulko, P.; Wozniak, M.; Lipinska, B.

Clinical significance of anti‐glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis
pp. 201-208(8)
Authors: Li, C‐. H.; Li, Y‐. C.; Xu, P‐. S.; Hu, X.; Wang, C‐. Y.; Zou, G‐. L.

Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls
pp. 217-223(7)
Authors: Demir, H.; Tanriverdi, F.; Özoğul, N.; Çaliş, M.; Kirnap, M.; Durak, A. C.; Keleştimur, F.

Restrictive cardiomyopathy in dermatomyositis
pp. 229-232(4)
Authors: Finsterer, J.; Stöllberger, C.; Avanzini, M.; Rauschka, H.

Giant cell arteritis presenting with aortic dissection: two cases and review of the literature
pp. 233-236(4)
Authors: Agard, C.; Ponge, T.; Fradet, G.; Baron, O.; Sagan, C.; Masseau, A.; Barrier, J. H.; Hamidou, M.

Aortic angiosarcoma clinically mimicking polyarteritis nodosa
pp. 237-240(4)
Authors: Sparsa, A.; Liozon, E.; Wechsler, J.; Soria, P.; Delage‐Core, M.; Loustaud, V.; Bedane, C.; Bonnetblanc, J‐M.; Vidal, E.

Influenza vaccination and the production of anti‐phospholipid antibodies in patients with systemic lupus erythematosus
pp. 241-243(3)
Authors: Tarján, P.; Sipka, S.; Lakos, G.; Kiss, E.; Ujj, G; Szegedi, G

Successful treatment with intravenous cyclophosphamide pulse therapy of severe intestinal involvement in Wegener's granulomatosis
pp. 243-245(3)
Authors: Kuwahara, Y.; Shima, Y.; Tanaka, T.; Kimura, H.; Hoshida, Y.; Aozasa, K.; Kawase, I.

Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension
pp. 245-247(3)
Authors: Chen, C‐H.; Chen, H‐A.; Yang, K‐Y.; Yu, W‐C.; Liao, H‐T.; Huang, D‐F.

Reversible posterior leucoencephalopathy syndrome in a patient with undifferentiated connective tissue disease
pp. 248-249(2)
Authors: Singh, S.; Balakrishnan, C.; Mangat, G.; Maheshwari, S.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page